To Be Discontinued Tablet Cardiovascular
Hydrochlorothiazide; Quinapr · 345 days since initial FDA posting
FDA lists Hydrochlorothiazide; Quinapr as To Be Discontinued (Pfizer Inc.).
No availability text on this FDA row.
Hydrochlorothiazide; Quinapril Hydrochloride Tablet: To Be Discontinued
FDA availability text is not recorded on this row. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Hydrochlorothiazide; Quinapril Hydrochloride Tablet
- Manufacturer
- Pfizer Inc.
- Dosage Form
- Tablet
- Presentation
- Accuretic, Tablet, 12.5 mg; 10 mg (NDC 0071-3112-23)
- Package NDC
- 0071-3112-23
Status & Timeline
- Status
- To Be Discontinued
- First Reported
- Oct 1, 2025
- Last Updated
- Oct 1, 2025
- Therapeutic Category
- Cardiovascular
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Discontinuation of the manufacture of the drug
Nearby, Other Hydrochlorothiazide; Shortage Records
FDA reason on file: Discontinuation of the manufacture of the drug. General shortage guidance lives on the tracker hub.